Dr. Eleanor Vance

• To ensure end-to-end visibility across complex global supply chains for advanced therapies, minimizing product loss and optimizing logistics for high-value biologics
• To implement robust risk mitigation strategies against theft, counterfeiting, and tampering, ensuring product integrity and patient safety throughout the distribution network
• To achieve and maintain stringent regulatory compliance (e.g., GDP) and provide irrefutable electronic chain of identity, condition, and custody reports for all sensitive products.

• Lack of real-time, comprehensive visibility across diverse logistics partners and geographies, leading to blind spots and delayed intervention for critical shipments
• Managing time-out-of-environment constraints and temperature excursions for highly sensitive and temperature-controlled products, impacting product viability and compliance
• Difficulty in integrating disparate legacy systems to gain a 'single pane of glass view' for supply chain data, hindering proactive decision-making and operational efficiency.